Dimethyl fumarate: targeting glycolysis to treat MS
- PMID: 29844579
- PMCID: PMC5993828
- DOI: 10.1038/s41422-018-0045-3
Dimethyl fumarate: targeting glycolysis to treat MS
Figures

Comment on
-
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.Science. 2018 Apr 27;360(6387):449-453. doi: 10.1126/science.aan4665. Epub 2018 Mar 29. Science. 2018. PMID: 29599194 Free PMC article.
Similar articles
-
Dimethyl Fumarate: A Review in Relapsing-Remitting MS.Drugs. 2016 Feb;76(2):243-54. doi: 10.1007/s40265-015-0528-1. Drugs. 2016. PMID: 26689201 Review.
-
Dimethyl Fumarate: A Review in Relapsing-Remitting MS.Drugs. 2019 Dec;79(18):1965-1976. doi: 10.1007/s40265-019-01229-3. Drugs. 2019. PMID: 31784875 Review.
-
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.Pediatr Neurol. 2016 Apr;57:101-4. doi: 10.1016/j.pediatrneurol.2016.01.010. Epub 2016 Jan 20. Pediatr Neurol. 2016. PMID: 26996405
-
Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US.Mult Scler Relat Disord. 2019 Jan;27:101-111. doi: 10.1016/j.msard.2018.09.038. Epub 2018 Oct 10. Mult Scler Relat Disord. 2019. PMID: 30368221
-
Comparing outcomes from clinical studies of oral disease-modifying therapies (dimethyl fumarate, fingolimod, and teriflunomide) in relapsing MS: Assessing absolute differences using a number needed to treat analysis.Mult Scler Relat Disord. 2016 Nov;10:204-212. doi: 10.1016/j.msard.2016.10.010. Epub 2016 Nov 3. Mult Scler Relat Disord. 2016. PMID: 27919491 Clinical Trial.
Cited by
-
Metabolic Regulation of Glial Phenotypes: Implications in Neuron-Glia Interactions and Neurological Disorders.Front Cell Neurosci. 2020 Feb 11;14:20. doi: 10.3389/fncel.2020.00020. eCollection 2020. Front Cell Neurosci. 2020. PMID: 32116564 Free PMC article. Review.
-
Repurposing Dimethyl Fumarate for Cardiovascular Diseases: Pharmacological Effects, Molecular Mechanisms, and Therapeutic Promise.Pharmaceuticals (Basel). 2022 Apr 19;15(5):497. doi: 10.3390/ph15050497. Pharmaceuticals (Basel). 2022. PMID: 35631325 Free PMC article. Review.
-
COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention.Obes Res Clin Pract. 2021 Mar-Apr;15(2):163-171. doi: 10.1016/j.orcp.2021.01.004. Epub 2021 Jan 19. Obes Res Clin Pract. 2021. PMID: 33509701 Free PMC article. Review.
-
An Epigenetic Role of Mitochondria in Cancer.Cells. 2022 Aug 13;11(16):2518. doi: 10.3390/cells11162518. Cells. 2022. PMID: 36010594 Free PMC article. Review.
-
Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis.J Neuroinflammation. 2024 Jan 20;21(1):28. doi: 10.1186/s12974-024-03016-8. J Neuroinflammation. 2024. PMID: 38243312 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources